| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $361.1M | +9.7% |
| R&D Expense | $18.2M | +15.0% |
| SG&A Expense | $53.5M | +10.9% |
| Operating Income | -$119.6M | -2463.6% |
| Interest Expense | $2.0M | -10.0% |
| Pre-tax Income | -$121.6M | -1138.7% |
| Income Tax | $1.8M | +622.0% |
| Net Income | -$123.3M | -1126.1% |
| EPS (Basic) | -$1.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.5M | -25.9% |
| Accounts Receivable | $63.2M | -10.1% |
| Current Assets | $92.2M | -14.0% |
| Total Assets | $184.0M | -42.2% |
| Current Liabilities | $50.2M | -13.3% |
| Long-term Debt | $35.6M | -21.5% |
| Total Liabilities | $90.0M | -14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.0M | -84.2% |
| Capital Expenditures | $17K | -52.8% |
| Investing Cash Flow | -$5.4M | -81.6% |
| Financing Cash Flow | -$5.4M | -320.7% |
| Free Cash Flow | $1.9M | -84.3% |
| -1061.5% |
| EPS (Diluted) | -$1.51 | -1061.5% |
| Stockholders' Equity |
| $94.0M |
| -56.0% |